P

Inventor

SONE SABURO

JP13 patents
⚠️ This page may combine multiple inventors who share the name “SONE SABURO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TORAY INDUSTRIES

3 patents
US6086869AJul 11, 2000

Use of interferon-β or γ to treat retinal edema

TORAY INDUSTRIES10 citations71
US5948403ASep 7, 1999

Corneal angiogenesis inhibitor

TORAY INDUSTRIES11 citations69
US6620411B1Sep 16, 2003

Method for inhibiting brain tumor or colon carcinoma

TORAY INDUSTRIES1 citations48

TANABE JUN-ICHI

2 patents
US8183044B2May 22, 2012

Recombinant human hepatitis C virus-like particle and method for producing the same

TANABE JUN-ICHI2 citations59
US8143022B2Mar 27, 2012

High production system for infectious hepatitis C virus particle

TANABE JUN-ICHI2 citations59

CHUGAI PHARMACEUTICAL CO LTD

2 patents
US7135609B2Nov 14, 2006

Non-human animal exhibiting bone metastasis of tumor cells and method of screening for bone metastasis inhibitors

CHUGAI PHARMACEUTICAL CO LTD3 citations55
US7402727B2Jul 22, 2008

Non-human animal exhibiting bone metastasis of tumor cells

CHUGAI PHARMACEUTICAL CO LTD0 citations45

WAKITA TAKAJI

2 patents
US8460912B2Jun 11, 2013

Nucleic acid construct containing full length genome of human hepatitis C virus, recombinant full length virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus particle

WAKITA TAKAJI0 citations48
US8454973B2Jun 4, 2013

Modified human hepatitis C virus genomic RNA that can be autonomously replicated

WAKITA TAKAJI0 citations48

TOKYO METROPOLITAN ORG MED RES

1 patent
US7659103B2Feb 9, 2010

Nucleic acid construct containing fulllength genome of human hepatitis C virus, recombinant fulllength virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus Particle

TOKYO METROPOLITAN ORG MED RES7 citations70

SAPPORO BREWERIES

1 patent
US5091511AFeb 25, 1992

Lymphokine activated killer suppressive factor (LAKSF), process for producing it and immunosuppressive agent comprising it

SAPPORO BREWERIES17 citations68

TOKYO METROPOLITAN INST MEDICAL SCIENCE

1 patent
US9175269B2Nov 3, 2015

Modified human hepatitis C virus genomic RNA that can be autonomously replicated

TOKYO METROPOLITAN INST MEDICAL SCIENCE0 citations48

SANTEN PHARAMCEUTICAL CO LTD

1 patent
US6969524B1Nov 29, 2005

Interferon complex and medicinal use thereof

SANTEN PHARAMCEUTICAL CO LTD0 citations40